September 20, 2023
TOPLINE: Nearly three-quarters of adults with alopecia areata (AA) were not receiving treatment 1 year after diagnosis, according to a retrospective cohort study using data from […]
September 20, 2023
TOPLINE: In a large cross-sectional study, nearly one third of patients with severe psoriasis met criteria for coronary microvascular dysfunction. METHODOLOGY: Prior studies with small sample […]
September 19, 2023
The European Commission has authorized the marketing of ritlecitinib to treat adults and adolescents 12 years of age and older with severe alopecia areata. This makes ritlecitinib […]
September 19, 2023
SAN DIEGO – In the clinical experience of Mathew M. Avram, MD, JD, fractional lasers work best in combination with other devices and wavelengths when treating signs of photoaging, […]
September 18, 2023
SAN DIEGO – Injecting a scar with intralesional steroids is a popular way to reduce its size and soften the surrounding tissue, but proper technique matters, according to […]
September 15, 2023
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended marketing authorization of lebrikizumab for the treatment of adult and […]
September 14, 2023
Patients with cutaneous Merkel cell carcinoma (MCC) have a higher risk of subsequently developing solid and hematologic cancers, according to a new analysis. In a cohort […]
September 12, 2023
Arcutis Biotherapeutics has submitted a supplemental New Drug Application (sNDA) to the Food and Drug Administration for roflumilast cream 0.15% for the treatment of mild to […]
September 11, 2023
SINGAPORE — Can the prolonged use of skin-lightening products, such as hydroquinone, lead to skin cancer? This question was posed by Ousmane Faye, MD, PhD, director […]